Combination chemotherapy for advanced br
โ
Gerard T. Kennealey; Barry Boston; Malcolm S. Mitchell; Mary Kathryn Knobf; Samu
๐
Article
๐
1978
๐
John Wiley and Sons
๐
English
โ 518 KB
Forty-eight women with advanced metastatic carcinoma of the breast were treated with one of two combination chemotherapy regimens: 1) adriamycin and cyclophosphamide or 2) adriamycin, cyclophosphamide, methotrexate and 5-fluorouracil. The response rate in the two-drug treatment group was 50% and in